Live Breaking News & Updates on Relay Therapeutics

Stay updated with breaking news from Relay therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

JMP Securities Reiterates Market Outperform Rating for Relay Therapeutics (NASDAQ:RLAY)

JMP Securities Reiterates Market Outperform Rating for Relay Therapeutics (NASDAQ:RLAY)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Leerink-partnrs , Norges-bank , Vanguard-group-inc , Nasdaq , Relay-therapeutics-inc , Bellevue-group , Relay-therapeutics , Free-report , Get-free-report , Finepoint-capital , Relay-therapeutics-daily

Relay Therapeutics (NASDAQ:RLAY) Receives "Outperform" Rating from Oppenheimer

Relay Therapeutics (NASDAQ:RLAY) Receives "Outperform" Rating from Oppenheimer
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Leerink-partnrs , Relay-therapeutics-company-profile , Norges-bank , Affinity-asset-advisors , Relay-therapeutics-inc , Bellevue-group , Relay-therapeutics , Free-report , Get-free-report , Relay-therapeutics-daily ,

Relay Therapeutics (NASDAQ:RLAY) Trading Down 5.2%

Relay Therapeutics (NASDAQ:RLAY) Trading Down 5.2%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Leerink-partnrs , Bellevue-group , Norges-bank , Vanguard-group-inc , Relay-therapeutics-inc , Relay-therapeutics-company-profile , Nasdaq , Relay-therapeutics , Get-free-report , Finepoint-capital , Relay-therapeutics-daily

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have issued a report on […] ....

Los-angeles , California , United-states , Leerink-partnrs , Stifel-nicolaus , Relay-therapeutics-inc , Los-angeles-capital-management , Relay-therapeutics-company-profile , Allspring-global-investments-holdings , Nasdaq , Mesirow-financial-investment-management-inc , Victory-capital-management-inc

Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Rating of "Buy" by Analysts

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has received a consensus recommendation of “Buy” from the six brokerages that are presently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have covered the stock in the last year […] ....

Switzerland , Los-angeles , California , United-states , New-york , Swiss , Leerink-partnrs , Stifel-nicolaus , Congress-asset-management-co , Nasdaq , Los-angeles-capital-management , York-state-common-retirement-fund